Anthony Barron is moderating Panel 24: Comprehensive Genomic Profiling (CGP): Can It Ever Bring Enough Value For Routine Clinical Practice?
CGP can improve patient outcomes, but is seen as unaffordable for routine adoption, despite its potential for downstream savings. This panel will debate the benefits and barriers of widespread CGP adoption and explore approaches that decision-makers can use to assess its long-term value, while considering if and how it can be implemented using current access pathways.
For more information on this event, click here.